KPMA executives oppose reference price system

Published: 2008-06-23 07:00:00

Updated: 2008-06-23 07:00:00

The minimum reference price system is expected to force many patients to give up being treated due to the high costs of original drugs, while local pharmaceutical companies have been developing a variety of generic drugs as patients want cheaper medication, according to the Korea Pharmaceutical M...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK